Abstract
The menopause may have several psychological effects, but this chapter will focus solely on depression, which is generally regarded as the most common effect. Depression at the menopause is often said to have three distinctive features. First, it is said that the risk of a woman becoming depressed at the menopause is exceptionally high. Second, menopausal depression is said to have special causes, notably lack of oestrogen. Third, the treatment of menopausal depression is said to be special, particularly in relation to the indications for hormone replacement therapy. The aim of this chapter, therefore, is to examine three questions:
-
1.
Is depression more frequent at the menopause than at other times in a woman’s life?
-
2.
Does such depression have special causes, whether physical or psychological?
-
3.
Does it have special treatment needs?
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Gelder MG, Gath D, Mayou R. Oxford textbook of psychiatry, 2nd edn. London: Oxford University Press, 1989.
Wing JK, Cooper JE, Sartorius N. The measurement and classification of psychiatric symptoms. London: Cambridge University Press, 1974.
Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6:278–96.
Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 131:431–2.
Beck AT, Ward CH, Mendelson M, Mock JE, Erbaugh JK. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561–71.
McKinlay S, Jeffereys M, Thompson P. An investigation of the age at menopause. J Biosoc Sci 1972; 4:161–73.
McKinlay SM, Jeffereys M. The menopausal syndrome. Br J Prev Soc Med 1974; 28:108–15.
Ballinger B. Psychiatric morbidity and the menopause: survey of a gynaecological out-patient clinic. Br J Psychiatry 1977; 131:83–9.
Byrne P. Psychiatric morbidity in a gynaecological clinic. An epidemiological survey. Br J Psychiatry 1984; 144:28–34.
Jones MJ, Marshall DH, Nordin BEC. Quantitation of menopausal symptomatology and its response to ethinyl oestradiol and piperazine oestrone sulphate. Curr Med Res Opin 1977; 4, Suppl. 3:12–20.
Ballinger B. Psychiatric morbidity and the menopause; screening of a general populative sample. Br Med J 1975; 3:344–6.
Hallstrom T, Samuelsson S. Mental health in the climacteric. The longitudinal study of women in Gothenburg. Acta Obstet Gynecol Scand [Suppl] 1985; 130:13–18.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd edn, revised. Washington DC: American Psychiatric Association, 1987.
Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1:385–401.
McKinlay JB, McKinlay SM, Brambila D. The relative contributions of endocrine changes and social circumstances to depression in middle-aged women. J Health Soc Behav 1987; 28:345–63.
Kaufert PA, Gilbert P, Hassaret T. Researching the symptoms of menopause: an exercise in methodology. Maturitas 1988; 10:117–31.
Goldberg DP. The detection of psychiatric illness by questionnaire. London: Oxford University Press, 1972.
Gath D, Cooper P, Bond A, Edmonds G. Hysterectomy and psychiatric disorder II. Demographic and physical factors in relation to psychiatric outcome. Br J Psychiatry 1982; 140:343–50.
Cooper P, Gath D, Fieldsend R, Rose N. Psychological and physical outcome after elective tubal sterilisation. J Psychosom Res 1981, 25:357–60.
Cooper P, Gath D, Rose N, Fieldsend R. Psychological sequelae to elective sterilisation in women: a prospective study. Br Med J 1981, 82:461–64.
Beyene Y. Cultural significance and physiological manifestations of menopause. A biocultural analysis. Cult Med Psychiatry 1986; 10:47–71.
George T. Menopause: some interpretations of the results of a study among non-western groups. Maturitas 1988, 10:109–16.
Paykel ES, Myers JK, Dienelt MN, Klerman GL, Lindenthal J, Pepper MP. Life events and depression: a controlled study. Arch Gen Psychiatry 1969; 21:753–60.
Greene JG, Cooke DJ. Life stress and symptoms at the climacterium. Br J Psychiatry 1980; 136:486–91.
Aylward M. Estrogens, plasma tryptophan levels in perimenopausal patients. In: Campbell S, ed. The management of the menopause and post-menopausal years. Lancaster: MTP Press, 1976; 135–47.
Coppen A, Bishop M, Beard RJ. Effects of piperazine oestrone sulphate on plasma tryptophan, oestrogen, gonadotrophins and psychological functioning in women following hysterectomy. Curr Med Res Opin 1977; 4, suppl 3:29–36.
Cowen PJ. Recent views on the role of 5-hydroxytryptamine in depression. Curr Opin Psychiatry 1988; 1:56–9.
Klaiber EL, Broverman DM, Vogel W, Kobayashi Y. Estrogen therapy for severe persistent depression in women. Arch Gen Psychiatry 1979; 36:550–4.
Chalmers JS, Fulli-Lemaire I, Cowen PJ. Effects of the contraceptive pill on sedative responses to clonidine and dapomorphine in normal women. Psychol Med 1985; 15:363–7.
Bungay GT, Vessey MP, McPherson CK. Study of symptoms in middle-life with special reference to the menopause. Br Med J 1980, 281:181–3.
Gath D, Osborn M, Bungay G, lies S, Day A, Bond A, Passingham C. Psychiatric disorder and gynaecological symptoms in middle-aged women: a community survey. Br Med J 1987; 294:213–218.
Sherwin B, Gelfand M. Sex steroids and affect in the surgical menopause: a double-blind, crossover study. Psychoneuroendocrinology 1985; 10:325–35.
Sherwin B. Affective changes with oestrogen and androgen replacement therapy in surgically menopausal women. J Affec̈ Dis 1988; 14:177–87.
Brincat M, Studd JWW, O’Dowd T, Magos A, Cardozo LD, Wardle PJ. Subcutaneous hormone implants for control of climacteric symptoms. Lancet 1984; i: 16–18.
Iatrakis G, Haronis N, Sakellaropoulos G, Kourkabas A, Gallos M. Psychosomatic symptoms of postmenopausal women with or without hormonal treatment. Psychother Psychosom 1986; 46:116–21.
Magos AL, Brincat M, Studd JWW. Treatment of the premenstrual syndrome by subcutaneous oestradiol implants and cyclical oral norethisterone: a placebo controlled study. Br Med J 1986; 292:1629–33
Magos AL, Brewster E, Singh R, O’Dowd T, Brincat M, Studd JWW. The effects of norethisterone in post-menopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome. Br J Obster Gynaecol 1986; 12:1290–6
. Fraser DI, Parsons A, Whitehead MI, Wordsworth J, Stuart G, Pryse-Davies J. The optimal dose of oral norethindrone acetate for addition to transdermal estradiol: a multicenter study. Fertil Steril (in press).
Campbell S, Whitehead M. Oestrogen therapy and the menopausal syndrome. In: Greenblatt R, Studd J. eds. The menopause: clinics in obstetrics and gynaecology IV. Philadelphia: WB Saunders, 1977; 31–47
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag London Limited
About this paper
Cite this paper
Gath, D., Iles, S. (1990). Psychological Effects of the Menopause. In: Drife, J.O., Studd, J.W.W. (eds) HRT and Osteoporosis. Springer, London. https://doi.org/10.1007/978-1-4471-1799-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4471-1799-5_4
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1801-5
Online ISBN: 978-1-4471-1799-5
eBook Packages: Springer Book Archive